According to Biolife Solutions 's latest financial reports the company's total assets are $0.41 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.41 B | -8.33% |
2022-12-31 | $0.45 B | -18.77% |
2021-12-31 | $0.55 B | 136.04% |
2020-12-31 | $0.23 B | 153% |
2019-12-31 | $92.81 M | 104.14% |
2018-12-31 | $45.46 M | 274.43% |
2017-12-31 | $12.14 M | 53.19% |
2016-12-31 | $7.92 M | -35.92% |
2015-12-31 | $12.36 M | -23.04% |
2014-12-31 | $16.07 M | 379.31% |
2013-12-31 | $3.35 M | 5.79% |
2012-12-31 | $3.16 M | 90.72% |
2011-12-31 | $1.66 M | 26.96% |
2010-12-31 | $1.3 M | -1.87% |
2009-12-31 | $1.33 M | 13.95% |
2008-12-31 | $1.17 M | 61.24% |
2007-12-31 | $0.72 M | 29.55% |
2006-12-31 | $0.56 M | 25.35% |
2005-12-31 | $0.44 M | -46.34% |
2004-12-31 | $0.83 M | -71.89% |
2003-12-31 | $2.96 M | 844.38% |
2002-12-31 | $0.31 M | -82.33% |
2001-12-31 | $1.77 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Celanese CE | $26.59 B | 6,344.41% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | $0.42 B | 3.82% | ๐บ๐ธ USA |
Amyris AMRS | $0.67 B | 64.69% | ๐บ๐ธ USA |